67 related articles for article (PubMed ID: 28355589)
1. Fluorescence resonance energy transfer usage to track the sequence promoter changes in CGB5 gene in ovarian cancer patients.
Andrusiewicz M; Skibińska I; Gąsiorowska E; Białas P; Kotwicka M
Biomed Pharmacother; 2017 Jun; 90():139-146. PubMed ID: 28355589
[TBL] [Abstract][Full Text] [Related]
2. A modest but significant effect of CGB5 gene promoter polymorphisms in modulating the risk of recurrent miscarriage.
Rull K; Christiansen OB; Nagirnaja L; Steffensen R; Margus T; Laan M
Fertil Steril; 2013 Jun; 99(7):1930-6.e6. PubMed ID: 23499152
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human chorionic gonadotropin beta subunit expression in ovarian cancer.
Śliwa A; Kubiczak M; Szczerba A; Walkowiak G; Nowak-Markwitz E; Burczyńska B; Butler S; Iles R; Białas P; Jankowska A
BMC Cancer; 2019 Jul; 19(1):746. PubMed ID: 31362717
[TBL] [Abstract][Full Text] [Related]
4. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
[TBL] [Abstract][Full Text] [Related]
5. Association of rs7260002 of chorionic gonadotrophin β5 with idiopathic recurrent spontaneous abortion in Chinese population.
Sun Y; Ji X
J Assist Reprod Genet; 2014 Nov; 31(11):1497-500. PubMed ID: 25193288
[TBL] [Abstract][Full Text] [Related]
6. Chorionic gonadotropin beta-gene variants are associated with recurrent miscarriage in two European populations.
Rull K; Nagirnaja L; Ulander VM; Kelgo P; Margus T; Kaare M; Aittomäki K; Laan M
J Clin Endocrinol Metab; 2008 Dec; 93(12):4697-706. PubMed ID: 18782867
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
Sun Y; Tao W; Huang M; Wu X; Gu J
J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.
Schüler S; Lattrich C; Skrzypczak M; Fehm T; Ortmann O; Treeck O
Gene; 2014 Aug; 546(2):283-7. PubMed ID: 24881814
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin β subunit affects the expression of apoptosis-regulating factors in ovarian cancer.
Szczerba A; Śliwa A; Kubiczak M; Nowak-Markwitz E; Jankowska A
Oncol Rep; 2016 Jan; 35(1):538-45. PubMed ID: 26530886
[TBL] [Abstract][Full Text] [Related]
12. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
13. [Association of functional polymorphisms on MMP-12 and MMP-13 gene promoter region with epithelial ovarian carcinoma].
Jia J; Kang S; Zhao J; Zhang X; Wang N; Zhou R; Li Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):209-13. PubMed ID: 20376807
[TBL] [Abstract][Full Text] [Related]
14. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in MMP-14 and MMP-2 genes and ovarian cancer survival.
Vos MC; van Tilborg A; Brands WJ; Boll D; van Hamont D; van der Putten H; Pijlman B; van der Wurff AAM; van Kuppevelt TH; Massuger LFAG
Cancer Biomark; 2019; 25(3):233-241. PubMed ID: 31282404
[TBL] [Abstract][Full Text] [Related]
17. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
[TBL] [Abstract][Full Text] [Related]
19. Expression of beta-human chorionic gonadotropin in ovarian cancer tissue.
Nowak-Markwitz E; Jankowska A; Andrusiewicz M; Szczerba A
Eur J Gynaecol Oncol; 2004; 25(4):465-9. PubMed ID: 15285305
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy.
Tecza K; Pamula-Pilat J; Kolosza Z; Radlak N; Grzybowska E
J Exp Clin Cancer Res; 2015 Jan; 34(1):2. PubMed ID: 25591549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
